Correlation Between Rallybio Corp and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Rallybio Corp and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rallybio Corp and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rallybio Corp and Champions Oncology, you can compare the effects of market volatilities on Rallybio Corp and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rallybio Corp with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rallybio Corp and Champions Oncology.

Diversification Opportunities for Rallybio Corp and Champions Oncology

0.57

Correlation Coefficient

Rallybio Corp  Champions Oncology

Very weak diversification

The 3 months correlation between Rallybio and Champions is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Rallybio Corp and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Rallybio Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rallybio Corp are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Rallybio Corp i.e., Rallybio Corp and Champions Oncology go up and down completely randomly.

Pair Corralation between Rallybio Corp and Champions Oncology

Given the investment horizon of 90 days Rallybio Corp is expected to under-perform the Champions Oncology. In addition to that, Rallybio Corp is 1.21 times more volatile than Champions Oncology. It trades about -0.07 of its total potential returns per unit of risk. Champions Oncology is currently generating about -0.01 per unit of volatility. If you would invest  506.00  in Champions Oncology on July 20, 2024 and sell it today you would lose (64.00) from holding Champions Oncology or give up 12.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Rallybio Corp  vs.  Champions Oncology

Rallybio Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Champions Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Champions Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Rallybio Corp and Champions Oncology

The main advantage of trading using opposite Rallybio Corp and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rallybio Corp position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Rallybio Corp and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.